Abstract
CA 19-9 has achieved a defined role in the diagnosis, prognosis, and monitoring of patients with pancreatic cancer. For diagnosis, a reference value above 200 u/mL in a nonjaundiced patient with a confirming CT scan has a very high predictive value. For prognosis, a low preoperative value and a normal value after resection predict a good outcome. Similarly, CA 19-9 levels have been used successfully in monitoring the response to neoadjuvant therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 93-101 |
| Number of pages | 9 |
| Journal | Surgical Oncology Clinics of North America |
| Volume | 7 |
| Issue number | 1 |
| State | Published - 1998 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Surgery
Cite this
CA 19-9 in pancreatic cancer. / Ritts, R. E.; Pitt, H. A.
In: Surgical Oncology Clinics of North America, Vol. 7, No. 1, 1998, p. 93-101.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - CA 19-9 in pancreatic cancer
AU - Ritts, R. E.
AU - Pitt, H. A.
PY - 1998
Y1 - 1998
N2 - CA 19-9 has achieved a defined role in the diagnosis, prognosis, and monitoring of patients with pancreatic cancer. For diagnosis, a reference value above 200 u/mL in a nonjaundiced patient with a confirming CT scan has a very high predictive value. For prognosis, a low preoperative value and a normal value after resection predict a good outcome. Similarly, CA 19-9 levels have been used successfully in monitoring the response to neoadjuvant therapy.
AB - CA 19-9 has achieved a defined role in the diagnosis, prognosis, and monitoring of patients with pancreatic cancer. For diagnosis, a reference value above 200 u/mL in a nonjaundiced patient with a confirming CT scan has a very high predictive value. For prognosis, a low preoperative value and a normal value after resection predict a good outcome. Similarly, CA 19-9 levels have been used successfully in monitoring the response to neoadjuvant therapy.
UR - http://www.scopus.com/inward/record.url?scp=0031886205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031886205&partnerID=8YFLogxK
M3 - Article
C2 - 9443988
AN - SCOPUS:0031886205
VL - 7
SP - 93
EP - 101
JO - Surgical Oncology Clinics of North America
JF - Surgical Oncology Clinics of North America
SN - 1055-3207
IS - 1
ER -